Osaic Holdings’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,161
| Closed | -$20.6K | – | 7387 |
|
|
2023
Q3 | $20.6K | Sell |
16,161
-20,949
| -56% | -$26.7K | ﹤0.01% | 5522 |
|
|
2023
Q2 | $12.2K | Sell |
37,110
-499
| -1% | -$164 | ﹤0.01% | 5832 |
|
|
2023
Q1 | $15.5K | Buy |
37,609
+6,250
| +20% | +$2.57K | ﹤0.01% | 5694 |
|
|
2022
Q4 | $16K | Buy |
31,359
+200
| +0.6% | +$102 | ﹤0.01% | 5710 |
|
|
2022
Q3 | $24K | Sell |
31,159
-1,300
| -4% | -$1K | ﹤0.01% | 5443 |
|
|
2022
Q2 | $38K | Buy |
32,459
+16,165
| +99% | +$18.9K | ﹤0.01% | 5159 |
|
|
2022
Q1 | $140K | Buy |
16,294
+3,632
| +29% | +$31.2K | ﹤0.01% | 4318 |
|
|
2021
Q4 | $36K | Buy |
12,662
+1,760
| +16% | +$5K | ﹤0.01% | 5384 |
|
|
2021
Q3 | $46K | Sell |
10,902
-450
| -4% | -$1.9K | ﹤0.01% | 5180 |
|
|
2021
Q2 | $59K | Sell |
11,352
-573
| -5% | -$2.98K | ﹤0.01% | 4916 |
|
|
2021
Q1 | $55K | Buy |
11,925
+590
| +5% | +$2.72K | ﹤0.01% | 4815 |
|
|
2020
Q4 | $36K | Sell |
11,335
-9,800
| -46% | -$31.1K | ﹤0.01% | 4768 |
|
|
2020
Q3 | $69K | Sell |
21,135
-11,020
| -34% | -$36K | ﹤0.01% | 4079 |
|
|
2020
Q2 | $108K | Buy |
32,155
+1,369
| +4% | +$4.6K | ﹤0.01% | 3624 |
|
|
2020
Q1 | $118K | Buy |
+30,786
| New | +$118K | ﹤0.01% | 3334 |
|